OPTISON

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom, United States, South Africa

Active ingredients

The drug OPTISON contains one active pharmaceutical ingredient (API):

1 Perflutren
UNII T8C6W1N6NW - HUMAN ALBUMIN MICROSPHERES

When used in conjunction with diagnostic ultrasound, perflutren provides opacification of cardiac chambers, improvement in delineation of endocardial borders, enhancement of the Doppler signal, and visualisation of wall motion and blood flow within the heart.

Read about Perflutren

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
OPTISON Dispersion for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V08DA01 V Various → V08 Contrast media → V08D Ultrasound contrast media → V08DA Ultrasound contrast media
Discover more medicines within V08DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1203051, 1203062
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 98065002
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 010529
Country: FR Base de données publique des médicaments Identifier(s): 67461741
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 342677
Country: IT Agenzia del Farmaco Identifier(s): 034650010, 034650022
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1030336, 1030337
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100172034
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W51612001, W51612002
Country: US FDA, National Drug Code Identifier(s): 0407-2707
Country: ZA Health Products Regulatory Authority Identifier(s): 34/28/0075

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.